E

Envisagenics

36 employees

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Splicing
RNA
Artificial Intelligence
Therapeutics
AI
Bioinformatics
Drug Discovery
Machine Learning
Deep Learning

Date founded

2014

Funding rounds raised

Total raised

$19M

from 12 investors over 12 rounds

E

Envisagenics raised $2M on August 2, 2022

Investors: National Cancer Institute

E

Envisagenics raised $19M on September 29, 2021

Investors: M12 - Microsoft's Venture Fund and Madrona Venture Group

E

Envisagenics raised $300K on October 23, 2019

Investors: National Cancer Institute

E

Envisagenics raised $1.5M on May 22, 2018

Investors: National Institutes of Health

E

Envisagenics raised $1M on May 1, 2018

Investors: Madrona Venture Group and M12 - Microsoft's Venture Fund

E

Envisagenics raised $2.4M on November 28, 2017

Investors: SV Angel, Dolby Family Ventures and New York State

E

Envisagenics raised $350K on April 13, 2017

Investors: The Thiel Foundation

E

Envisagenics raised undisclosed on July 1, 2016

Investors: Grand Central Tech

FAQ